GlassScriptPhysician profile
William Alfred Kramer
NPI 1982600987
$1,971.35
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,180 · 2020: $791.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $283.27 | 2019-2020 | |
| Pfizer INC. | $241.75 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $226.50 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $145.94 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $130.82 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $114.68 | 2019-2020 | |
| Astellas Pharma US INC | $108.19 | 2019-2020 | |
| Amarin Pharma, INC. | $92.88 | 2019-2020 | |
| Glaxosmithkline, LLC. | $80.20 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $71.96 | 2019-2020 | |
| Lilly USA, LLC | $68.93 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $56.15 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $52.12 | 2019-2020 | |
| Mylan Specialty L.P. | $47.68 | 2019-2020 | |
| Radius Health, INC. | $44.71 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $43.89 | 2019 | |
| Mannkind Corporation | $41.91 | 2019-2020 | |
| Amgen INC. | $35.77 | 2019 | |
| Abbvie INC. | $19.39 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.00 | 2019 | |
| Sanofi Pasteur INC. | $12.83 | 2019 | |
| Ironshore Pharmaceuticals INC. | $12.74 | 2019 | |
| Indivior INC. | $11.98 | 2020 | |
| Allergan, INC. | $11.06 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Kramer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.